Welcome to Valicare!
You process highly active substances and need to be sure that your environment and product are protected? With the SMEPAC test, we check the tightness of your containment system. Read about it in the newsletter of our experts.Mehr erfahren
GMP for ATMPs
Also, still in the development phase manufacturing of your ATMP is already in your mind? Which steps need to be done first and which regulatory requirements need to be followed? Ask our experts.Learn more
Events where you can meet Valicare experts
News from around the world
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa19.05.2023 | FDA
For Immediate Release: May 19, 2023 ...
A Guide to Mesenchymal Stem Cell (MSC) Markers19.05.2023 | Biocompare
Mesenchymal stem cells are non-hematopoietic multipotent precursor cells that can differentiate into a variety of cell types, including ...
“Untargeting” autoantibodies using genome editing, a proof-of-concept study19.05.2023 | Science Direct
... https://doi.org/10.1016/j.clim.2023.109343 ...
Imugene receives FDA approval to start human trial of CAR-T cell therapy for solid tumours19.05.2023 | Small Caps
Cancer immunotherapy house Imugene (ASX: IMU) has received US Food and Drug Administration (FDA) approval to start a human trial targeting ...
Rescued from the rubbish bin: How the thymus could stop organ transplant rejection18.05.2023 | BC Children's Hospital Research Institute
Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds18.05.2023 | Science Direct
... https://doi.org/10.1016/j.chemphyslip.2023.105304 ...
Around the Helix: Cell and Gene Therapy Company Updates – May 17, 202317.05.2023 | CGTLive
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
EMA Publishes Annual Report for 202217.05.2023 | Pharmaceutical Technology
The report outlines highlights from the agency’s medicines evaluations and milestones for 2022.
Spinnenseide für Gewebe und Implantat17.05.2023 | medizin & technik
Evolving Tools and Perspectives for the Development of Cell and Gene Therapies16.05.2023 | Applied Clinical Trials
This year marks the first time multiple gene therapies for the same non-oncology rare disease may be market authorized in the United States ...
FDA Awards FTD of IMPT-314 for B-Cell Mediated Malignancies16.05.2023 | Targeted Oncology
The fast track designation to IMPT-314 is for the treatment of multiple types of B-cell lymphoma in patients who previously received 2 or ...
ReviewViral Vectors, Exosomes, and Vexosomes: Potential armamentarium for delivering CRISPR/Cas to cancer cells16.05.2023 | Science Direct
... https://doi.org/10.1016/j.bcp.2023.115555 ...
Advanced flexible materials made from nanocellulose16.05.2023 | Nanowerk
May 16, 2023 Advanced flexible materials made from nanocellulose ( Nanowerk Spotlight ) Nanocellulose, a specialized type of cellulose ...
Researchers map RNA to inform selection of stem cells for therapeutic applications12.05.2023 | The Science Advisory Board
By Nick Paul Taylor, The Science Advisory Board contributing writer ...
What is the Best Lymphoma Treatment After CAR T Therapy Fails?12.05.2023 | Cancer Health
... iStock/Catalin Rusnac CU Cancer Center member Ajay Major published research showing that checkpoint inhibitor therapies are not ...
Valicare – competent, reliable & efficient
You have little time and still want to know what services Valicare GmbH offers?